Ambu A/S (OTCMKTS:AMBBY) Announces Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY) released its earnings results on Thursday. The company reported $0.14 EPS for the quarter, Zacks reports. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%.

Ambu A/S Price Performance

OTCMKTS:AMBBY traded down $0.60 during trading hours on Friday, hitting $13.00. The company’s stock had a trading volume of 500 shares, compared to its average volume of 16. The stock has a fifty day simple moving average of $11.15 and a 200-day simple moving average of $10.98. The company has a market capitalization of $3.05 billion, a P/E ratio of 35.14 and a beta of 0.86. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.77 and a quick ratio of 1.69. Ambu A/S has a twelve month low of $8.54 and a twelve month high of $14.18.

Wall Street Analyst Weigh In

Separately, UBS Group lowered shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, Ambu A/S presently has a consensus rating of “Hold”.

About Ambu A/S

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.